Exacerbation of ozone-induced pulmonary and systemic effects by 2-adrenergic and/or glucocorticoid agonist/s

OwnerUnited State Environmental Protection Agency - view all

Update frequencyunknown

Last updatedabout 1 year ago

Format

Overview

This data set pertains to the manuscript "Exacerbation of ozone-induced pulmonary and systemic effects by 2-adrenergic and/or glucocorticoid agonist/s". It shows the raw data for each figure in the manuscript that is created with these data. Basically examining the influence of beta adrenergic and glucocorticoid receptor agonists on ozone-induced lung injury and inflammation. This dataset is associated with the following publication: Henriquez, A., S. Snow, M. Schladweiler, C. Miller, J. Dye, A. Ledbetter, M. Hargrove, U. Kodavanti, and J. Richards. Exacerbation of ozone-induced pulmonary and systemic effects by beta2-adrenergic and/or glucocorticoid agonist/s. Scientific Reports. Nature Publishing Group, London, UK, 9(1): 17925, (2019).

clenbuterol dexamethasone glucocorticoid lung inflammation ozone systemic metabolic

Additional Information

KeyValue

dcat_modified2019-11-11

dcat_publisher_nameU.S. EPA Office of Research and Development (ORD)

guidhttps://doi.org/10.23719/1518675

ib1_trust_framework[]

language

Files